Glenmark Pharmaceuticals Ltd.(GLENMARK) · NSE
Sector: CNXPHARMA | Last updated: 30 Aug 2026
Glenmark Pharmaceuticals Ltd. (GLENMARK) is showing Strong Bullish momentum today, with an Altra Score of 83.5 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the CNXPHARMA sector, where it ranks 6 by relative strength in a currently neutral RS regime (Relative Strength: 9.32). There are no active EMA crossover signals at the moment. GLENMARK closed at 2480.00 on 30 Aug 2026 (-2.07% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
No active signals
GLENMARK's Daily RSI(14) is 67.6 (down 5.8 from prior), Weekly RSI is 66.2 (down 3.0 from prior), and Monthly RSI is 72.8 (up 6.6 from prior). Price is currently trading above its Daily EMA 8, Daily EMA 20, Daily EMA 50, Daily EMA 200, Weekly EMA 8, Weekly EMA 30.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 67.6 | 73.4 | ▼ 5.8 |
| Weekly | 66.2 | 69.3 | ▼ 3.0 |
| Monthly | 72.8 | 66.2 | ▲ 6.6 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for GLENMARK is Bullish, triggered on 06 Jun 2025 at a price of 1590.20. Since then, the stock has gained 55.96%.
These are long-term momentum shifts, not buy/sell recommendations.
Price Chart — GLENMARK
Open on TradingViewLive chart not available for NSE stocks in the free embed. View GLENMARK on TradingView ↗